These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 10790089
1. Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. Waites K, Johnson C, Gray B, Edwards K, Crain M, Benjamin W. J Clin Microbiol; 2000 May; 38(5):1731-4. PubMed ID: 10790089 [Abstract] [Full Text] [Related]
2. Distribution of mefE and ermB genes in macrolide-resistant strains of Streptococcus pneumoniae and their variable susceptibility to various antibiotics. Nishijima T, Saito Y, Aoki A, Toriya M, Toyonaga Y, Fujii R. J Antimicrob Chemother; 1999 May; 43(5):637-43. PubMed ID: 10382884 [Abstract] [Full Text] [Related]
3. High frequency of erythromycin A resistance and distribution of mefE and ermB genes in clinical isolates of Streptococcus pneumoniae in Japan. Okamoto H, Tateda K, Ishii Y, Matsumoto T, Kobayashi T, Miyazaki S, Yamaguchi K. J Infect Chemother; 2002 Mar; 8(1):28-32. PubMed ID: 11957116 [Abstract] [Full Text] [Related]
10. High prevalence of multidrug-resistant international clones among macrolide-resistant Streptococcus pneumoniae isolates in immunocompromised patients in Tunisia. Raddaoui A, Tanfous FB, Chebbi Y, Achour W, Baaboura R, Benhassen A. Int J Antimicrob Agents; 2018 Dec; 52(6):893-897. PubMed ID: 29698665 [Abstract] [Full Text] [Related]
11. In vitro development of resistance to telithromycin (HMR 3647), four macrolides, clindamycin, and pristinamycin in Streptococcus pneumoniae. Davies TA, Dewasse BE, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2000 Feb; 44(2):414-7. PubMed ID: 10639373 [Abstract] [Full Text] [Related]
12. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK. Johnson AP, Henwood CJ, Tysall L, Warner M. Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530 [Abstract] [Full Text] [Related]
13. Phenotypic and genotypic characterization of Streptococcus pneumoniae resistant to macrolide in Casablanca, Morocco. Diawara I, Zerouali K, Katfy K, Barguigua A, Belabbes H, Timinouni M, Elmdaghri N. Infect Genet Evol; 2016 Jun; 40():200-204. PubMed ID: 26961592 [Abstract] [Full Text] [Related]
14. [Comparison of antimicrobial and bactericidal activities and postantibiotic effects of macrolides antibiotics against clinical isolates, and examination of shape alteration by scanning electron microscope]. Yano H, Kobayashi T, Okitsu N, Aoki A, Toriya M, Nakada Y, Sagai H, Iyobe S, Inoue M. Jpn J Antibiot; 2007 Feb; 60(1):31-46. PubMed ID: 17436861 [Abstract] [Full Text] [Related]
16. Macrolide-resistance mechanisms in Streptococcus pneumoniae isolates from Chinese children in association with genes of tetM and integrase of conjugative transposons 1545. Shen X, Yang H, Yu S, Yao K, Wang Y, Yuan L, Yang Y. Microb Drug Resist; 2008 Jun; 14(2):155-61. PubMed ID: 18479199 [Abstract] [Full Text] [Related]
19. Antipneumococcal activity of ABT-773 compared to those of 10 other agents. Davies TA, Ednie LM, Hoellman DM, Pankuch GA, Jacobs MR, Appelbaum PC. Antimicrob Agents Chemother; 2000 Jul; 44(7):1894-9. PubMed ID: 10858350 [Abstract] [Full Text] [Related]
20. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes. Mason EO, Wald ER, Bradley JS, Barson WJ, Kaplan SL, United States Pediatric Multicenter Pneumococcal Surveillance Study Group. Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838 [Abstract] [Full Text] [Related] Page: [Next] [New Search]